D. Eugene Wampler
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Biotechnology top 5%
- Transgenic Plants and Applications
Papers in
-
- Hepatitis B Virus Studies 6
- Co-authors
- W. J. McAleer (5 shared papers)Eugene B. Buynak (4 shared papers)Robert Z. Maigetter (4 shared papers)William J. Miller (4 shared papers)M. R. Hilleman (2 shared papers)Edward W. Westhead (2 shared papers)Joshua Boger (1 shared paper)E. Dale Lehman (2 shared papers)
- Journals
- Biochemistry (4 papers)Archives of Biochemistry and Biophysics (2 papers)Proceedings of the National Academy of Sciences (2 papers)Blood (2 papers)Experimental Biology and Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
D. Eugene Wampler
19 papers receiving 853 citations
D. Eugene Wampler's Hit Papers
Peers
Comparison fields: 5 of 89
- Hepatology 136
- Biotechnology 114
- Virology 54
- Epidemiology 354
- Biochemistry 72
Countries citing papers authored by D. Eugene Wampler
This map shows the geographic impact of D. Eugene Wampler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Eugene Wampler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Eugene Wampler more than expected).
Fields of papers citing papers by D. Eugene Wampler
This network shows the impact of papers produced by D. Eugene Wampler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Eugene Wampler. The network helps show where D. Eugene Wampler may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Eugene Wampler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Human hepatitis B vaccine from recombinant yeast Hit paper breakdown → | 1984 | 529 |
| 2 | 1968 | 93 | |
| 3 | 1985 | 88 | |
| 4 | 1974 | 55 | |
| 5 | 1976 | 32 | |
| 6 | 1994 | 24 | |
| 7 | 1972 | 24 | |
| 8 | 1970 | 21 | |
| 9 | 1978 | 19 | |
| 10 | 1983 | 16 | |
| 11 | 1984 | 16 | |
| 12 | 1974 | 10 | |
| 13 | Human hepatitis B vaccine from recombinant yeast. 1984. | 1992 | 10 |
| 14 | 1967 | 10 | |
| 15 | 1989 | 7 | |
| 16 | 1964 | 5 | |
| 17 | 1977 | 4 | |
| 18 | 1971 | 3 | |
| 19 | 1977 | 2 | |
| 20 | 2024 | 0 |
About D. Eugene Wampler
D. Eugene Wampler is a scholar working on Molecular Biology, Epidemiology, Ecology, Biotechnology and Biochemistry, having authored 20 papers that have together received 968 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Bacteriophages and microbial interactions (4 papers), Transgenic Plants and Applications (4 papers), Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (3 papers), Hemophilia Treatment and Research (2 papers), Pancreatic function and diabetes (2 papers) and Field-Flow Fractionation Techniques (2 papers). The work is most often cited by research in Hepatology (136 citations), Biotechnology (114 citations), Virology (54 citations), Epidemiology (354 citations) and Biochemistry (72 citations). D. Eugene Wampler has collaborated with scholars based in United States. Frequent co-authors include W. J. McAleer, Eugene B. Buynak, Robert Z. Maigetter, William J. Miller, M. R. Hilleman, Edward W. Westhead, Joshua Boger, E. Dale Lehman, Edward M. Scolnick and Marvin L. Tanzer. Their work appears in journals such as Biochemistry, Archives of Biochemistry and Biophysics, Proceedings of the National Academy of Sciences, Blood and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.